Duramorph PF injection and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Duramorph PF injection and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: morphine
Brand name: Duramorph PF, Infumorph, Mitigo, Arymo ER, Kadian, MorphaBond ER, Avinza, MS Contin, RMS, Roxanol
Synonyms: Duramorph PF (injection)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Duramorph PF injection-Moxifloxacin
- Duramorph PF injection-Moxifloxacin (Systemic)
- Duramorph PF injection-Moxifloxacin Hydrochloride
- Duramorph PF injection-Moxifloxacin Injection
- Duramorph PF injection-Moxifloxacin Intravenous
- Duramorph PF injection-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Durapren Injection
- Moxetumomab pasudotox-tdfk Intravenous-DuraProxin ES
- Moxetumomab pasudotox-tdfk Intravenous-Durasal
- Moxetumomab pasudotox-tdfk Intravenous-Durasal Topical
- Moxetumomab pasudotox-tdfk Intravenous-DuraTan DM
- Moxetumomab pasudotox-tdfk Intravenous-Duration